Young John J, Phillips Harry R, Marso Steven P, Granada Juan F, McPherson John A, Waksman Ron, Steinhubl Steven R, Schwartz Robert S, Stone Gregg W
Swedish Heart and Vascular Institute, Seattle, Washington 98122, USA.
Catheter Cardiovasc Interv. 2008 Feb 15;71(3):367-74. doi: 10.1002/ccd.21354.
Progressive atherosclerotic disease is responsible for many of the late adverse clinical events that detract from the high procedural and clinical success of percutaneous coronary intervention. Despite recent advances in catheter based technology for the treatment of obstructive coronary artery disease, the greater risk to the patient over time may in fact come from the significant rate of acute coronary events triggered by nonculprit and/or nonobstructive coronary artery lesions. These areas of vulnerability within the epicardial coronary tree have generated a great deal of interest surrounding the concepts of vulnerable plaque (VP), vulnerable blood and the vulnerable patient. This 'state of the art' review discusses the limitations of coronary angiography alone in providing risk assessment; reviews the underlying biological concepts of VP; discusses evolving noninvasive and invasive imaging technologies for the detection of VP; and finally provides a futuristic look at how the field of interventional cardiology may transcend the traditional angiogram and move toward a more comprehensive treatment approach that benefits the patients' overall coronary health.
进展性动脉粥样硬化疾病是导致许多晚期不良临床事件的原因,这些事件降低了经皮冠状动脉介入治疗的高手术成功率和临床成功率。尽管近年来基于导管的技术在治疗阻塞性冠状动脉疾病方面取得了进展,但随着时间的推移,患者面临的更大风险实际上可能来自非罪犯和/或非阻塞性冠状动脉病变引发的急性冠状动脉事件的高发生率。心外膜冠状动脉树内的这些易损区域引发了人们对易损斑块(VP)、易损血液和易损患者概念的极大兴趣。这篇“最新技术”综述讨论了仅依靠冠状动脉造影进行风险评估的局限性;回顾了VP的潜在生物学概念;讨论了用于检测VP的不断发展的非侵入性和侵入性成像技术;最后展望了介入心脏病学领域如何超越传统血管造影,朝着更全面的治疗方法发展,从而有益于患者的整体冠状动脉健康。